Keywords: ec, clears, pegasys, hep, hiv, co-infection, swiss

EC clears Pegasys for hep C + HIV co-infection

Article | 07 February 2005

Print This

Swiss drugmaker Roche says that the European Commission has approved its Pegasys (peginterferon alfa-2a) in combination with ribavirin for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in